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b-Selection: Abundance of TCRb–/cd– CD44–CD25– (DN4)
cells in the foetal thymus
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Johannes T. Dessens2 and Tessa Crompton1
1 Division of Cell and Molecular Biology, Faculty of Natural Sciences, Imperial College
London, London, UK
2 Department of Infectious and Tropical Diseases, London School of Hygiene and
Tropical Medicine, London, UK
Expression of TCRb and pre-TCR signalling are essential for differentiation of CD4–CD8–
double negative (DN) thymocytes to the CD4+CD8+ double-positive (DP) stage.
Thymocyte development in adult Rag1, Rag2 or TCRbd-deficient mice is arrested at the
DN3 stage leading to the assumption that pre-TCR signalling and b-selection occur at,
and are obligatory for, the transition from DN3 to DN4. We show that the majority of
DN3 and DN4 cells that differentiate during early embryogenesis in wild-type mice do
not express intracellular (ic) TCRb/cd. These foetal icTCRb–/cd– DN4 cells were T
lineage as determined by expression of Thy1 and icCD3 and TCRbDJ rearrangement. In
addition, in the foetal Rag1–/– thymus, a normal percentage of DN4 cells were present.
In wild-type mice after hydrocortisone-induced synchronisation of differentiation, the
majority of DN4 cells that first emerged did not express icTCRb/cd, showing that adult
thymocytes can also differentiate to the DN4 stage independently of pre-TCR signalling.
Pre-TCR signalling induced expansion in the DN4 population, but lack of TCRb/cd
expression did not immediately induce apoptosis. Our data demonstrate in vivo
differentiation from DN3 to DN4 cell in the absence of TCRb/cd expression in the foetal
thymus, and after hydrocortisone treatment of adult mice.
Introduction
Signalling through the pre-T cell receptor (TCR) is
essential for differentiation of CD4–CD8– double-nega-
tive (DN) thymocytes to the CD4+CD8+ double-positive
(DP) stage [1, 2]. The DN population can be sub-divided
into four subsets, DN1–DN4, depending on the expres-
sion of the cell surface molecules CD44 and CD25. The
earliest CD44+CD25– (DN1) cells give rise to the
CD44+CD25+ (DN2) population that progresses to
the CD25+CD44– (DN3) stage, and then to the
CD44–CD25– (DN4) population [3]. Expression of
rearranged TCRb and formation of the pre-TCR complex
leads to a series of events collectively known as
b-selection, resulting in allelic exclusion of the TCRb
locus, expansion and differentiation to the DP stage [4].
Several studies have indicated that thymocytes that
successfully pass the b-selection checkpoint receive pre-
TCR induced signals for proliferation [4–6] and survival
[7, 8]. Recently, BCL2A1 has been identified as an anti-
apoptotic agent that is up-regulated following pre-TCR
signalling [9].
Rearrangement of the TCRb locus and expression of
a functional TCRb chain are essential for differentiation,
and the development of thymocytes in adult mice
deficient in Rag1 [10], Rag2 [11] or TCRbd [12] is
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arrested at the DN3 stage. The fact that T cell
development in these mice is arrested at the DN3 stage
has lead to the assumption that pre-TCR signalling and
b-selection occur at the transition from DN3 to DN4 and
are obligatory for differentiation beyond the DN3 stage
of development. Contrary to this assumption, rare DN4
cells that do not express TCRb or cd have been detected
in adult wild-type mice [7]. As cell death is increased in
this TCRb–/cd– DN4 population, it has been suggested
that cells that fail b-selection die at the DN4 stage [7].
Here we show that in the wild-type foetal thymus
differentiation from DN3 to DN4 frequently occurs
independently of TCRb/cd expression (and hence
normal pre-TCR signalling).
In addition, in the foetal Rag1–/– thymus a normal
percentage of DN4 cells were present, although no DP
cells were observed. In the foetal thymus, T cell
development occurs in a largely synchronized wave
[13], allowing the study of thymocyte populations as
they first emerge, and enabling the definition of
requirements for the transition of cells from one
population to the next. After synchronizing adult
thymocyte development by hydrocortisone treatment,
the majority of DN4 cells that emerge in vivo in the adult
thymus do not express intracellular (ic) TCRb/cd.
Results
The majority of early foetal DN4 thymocytes do
not express icTCRb or cd
Analysis of TCRb expression in foetal thymocytes
revealed a large population of CD3–CD4–CD8– triple
negative DN4 cells (CD44–CD25–) that did not express
detectable icTCRb. We analysed the intracellular
expression of TCRb in DN3 and DN4 cells of embryonic
day (E) 15.5, E16.5 and adult wild-type thymi. DN3 and
DN4 subsets that fell within the live FSC/SSC gate were
identified by positive staining for anti-Thy1.2, presence
or absence, respectively, of cell surface expression of
CD25 and the absence of CD44, CD3, CD4, CD8
expression (Fig. 1A). In a typical experiment, on
E15.5, 12.66% of the DN3 cells and 15.23% of the
DN4 cells expressed icTCRb (Fig. 1B). The percentage of
icTCRb+ cells increased in both DN3 and DN4 subsets on
E16.5 and in a typical experiment 18.41% of the DN3
and 54.59% of the DN4 cells expressed icTCRb (Fig. 1C).
On E16.5, approximately 12% of icTCRb– DN4 cells
stained positively for icTCRcd expression (Fig. 1C).
Thus, 40% of DN4 cells on E16.5 did not express either
icTCRb or TCRcd. As previously shown, in the adult
thymus, 18.49% of DN3 and 90.45% of DN4 cells
expressed icTCRb (Fig. 1D).
The fact that the majority of the E15.5 foetal DN4
thymocytes were icTCRb– was surprising as, in contrast
to the adult thymus [5, 7, 14, 15], in the foetal E15.5
thymus there was no enrichment for icTCRb+ cells in the
DN4 population compared to the DN3 subset (Fig. 1),
suggesting that the foetal TCRb+ DN3 cells did not
preferentially differentiate to the DN4 stage compared to
the foetal TCRb– DN3 cells. Analysis of icCD3 expression
confirmed that the icTCRb– DN4 cells were T lineage
cells. Both icTCRb– and icTCRb+ DN4 cells expressed
icCD3 and 54% of the icTCRb– and 90% of the icTCRb+
DN4 cells expressed icCD3 at high level (Fig. 1E).
Given the reduction in the proportion of icTCRb–
DN4 cells present in the thymus from E15.5 to E16.5 to
adult, it seemed likely that icTCRb– DN4 cells are
gradually removed from the thymus from E15.5
onwards. We therefore calculated the absolute numbers
of icTCRb– and icTCRb+ DN4 cells in the thymus on
E15.5, E16.5 and in adults. We found that the number of
icTCRb– DN4 thymocytes in fact increases over time but
to a lesser extent than the number of icTCRb+ DN4 cells,
accounting for the reduction in overall percentage
(Fig. 1F).
DN4 cells develop in Rag1–/– foetal thymus
The presence of icTCRb– DN4 cells in the first wave of
differentiation of wild-type foetal thymocytes led us to
ask whether DN4 cells are present in Rag1–/– foetal
thymi.We analysed Rag1–/– foetal thymi at E15.5, E16.5,
E17.5, thymi at 3 weeks postnatally (juvenile) and adult
thymi and observed a substantial DN4 population on all
embryonic days tested (Fig. 2A, B), whereas the
percentage of DN4 thymocytes was extremely small in
the adult thymus of Rag1–/– mice as previously reported
[10]. In a typical experiment, 31.12% of the thymocytes
were DN4 on E15.5 compared to only 0.76% of the adult
thymocytes. The percentage of DN4 thymocytes gradu-
ally decreased over time until they were virtually
undetectable in the adult thymus (Fig. 2B). Correspond-
ingly, the percentage of DN3 cells increased substan-
tially from E15.5 to E16.5 and thereafter the thymus
consisted mainly of DN3 thymocytes (Fig. 2B). As
expected, no TCRb expression or DP thymocytes were
observed at any stage of embryonic or postnatal
development in Rag1–/– mice (data not shown).
Although the percentage of Rag1–/– DN4 thymocytes
gradually decreased over time after E15.5, the absolute
number of DN4 cells did not change appreciably,
whereas the number of DN3 cells increased (Fig. 2C).
The Rag1–/– DN4 cells observed, as defined by the
absence of CD44 and CD25 cell surface markers, were
true T lineage DN4 cells as the majority stained positive
for cell surface expression of HSA (94.22%) and
expressed intracellular CD3 (Fig. 2D). In contrast, in
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Figure 1. Analysis of DN3 and DN4 foetal and adult wild type thymocytes. (A) Gates for the identification of DN3 and DN4 subsets
(shown for E16.5 thymus). Thymocytes in the live FSC/SSC gate (left) were determined as DN3 or DN4 when falling in the gate
negative for anti-CD3/CD4/CD8/CD44 and positive for anti-Thy1.2 antibody staining (middle) and positive or negative for anti-
CD25 staining (right), respectively. (B–D) Percentages of icTCRb+ cells among CD44–CD25+ TN (DN3) and CD44–CD25– TN (DN4)
subsets are shown for E15.5 (B), E16.5 (C) and adult thymus (D). The percentage of icTCRcd+ cells in the icTCRb– DN4 subset on E16.5
is also shown (C). (E) Expression of icCD3 in DN3, icTCRb– and icTCRb+ DN4 thymocytes. Expression of icCD3 in DN3 cells is shown
in the top, icTCRb– DN4 in themiddle and icTCRb+ DN4 cells in the lower panel. Percentages of high and low icCD3 expression are
shown for the DN3 and icTCRb– DN4 subsets. The dotted line in all histograms represents the expression of icCD3 in B
lymphocytes, similar in size to thymocytes and isolated from lymphnodes of adultwild-typemice, and is a negative control for the
icCD3 staining. (F) Kinetics of icTCRb– and icTCRb+ DN4 thymocyte number. The number of icTCRb– DN4 and icTCRb+ DN4
thymocytes are shown for E15.5, E16.5 and adult thymi. Bars represent themean of at least three thymi and error bars the standard
error of the mean.
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Figure 2.Analysis of Rag1–/– thymocyte subsets. (A) CD44 andCD25 expression in E15.5 and adult Rag1–/– thymocytes. Top panel are
FSC/SSC dot plots profiles of E15.5 and adult thymocytes; live gates are shown. Profiles in the lower panel show cells that fell in the
live gate andwere negative for anti-CD3/CD4/CD8 antibody staining. CD44 against CD25 dot plots and percentages of cells in each
quadrant are given for E15.5 (left) and adult (right). (B) Graph representing the percentages of thymocytes in the DN3 and DN4
subsets in E15.5, E16.5, E17.5, juvenile (3-week-old) and adult Rag1–/– mice. (C) Absolute number of DN3 and DN4 cells in the E15.5,
E16.5 and adult Rag1–/– thymi. Bars represent themeanof at least threemice. Cellsweregated positive for Thy1.2 staining, negative
for CD4, CD8 andCD44 expression and positive or negative for CD25 surface expression, respectively. (D) Expression of lymphocyte
markers in E15.5 DN4 Rag1–/– thymocytes. Histograms show the expression of HSA, icCD3, NK1.1, B220 in CD44–CD25– cells and the
percentage of CD44–CD25– cells positive for eachmarker are shown. Cells were gated negative for CD25, CD44, CD3, CD4 and CD8.
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a typical experiment only 0.42% stained positive with
anti-NK1.1 and 8.58% with anti-B220 antibodies
(Fig. 2D).
Transcription of Rag1 and Rag2 is down-regulated
in the foetal DN4 population
It has been shown that transcription of Rag1 and to a
lesser extent Rag2 is down-regulated in adult DN4 cells
relative to DN3 cells [16]. To test whether down-
regulation of the Rag genes in the DN4 relative to the
DN3 population depended on the expression of TCRb/
cd, we analysed the transcription of Rag1 and Rag2 by
quantitative RT-PCR in DN3 and DN4 thymocytes sorted
from E15.5, E16.5 and adult wild-type thymi. Rag1
transcripts were two to four times less abundant in DN4
thymocytes compared to DN3 cells (Fig. 3A, left panel).
More than 80% of DN4 thymocytes on day E15.5 did not
express TCRb, suggesting that down-regulation of Rag1
in the DN4 subset on day E15.5 was independent of pre-
TCR signalling. Rag2 transcription was also significantly
decreased in foetal DN4 thymocytes compared to DN3
cells but the difference in Rag2 expression in the adult
thymocyte population was not significant (Fig. 3A, right
panel). When foetal and adult Rag1–/– thymocytes were
treatedwith antiCD3 antibody for 24 h tomimic the pre-
TCR signal, down-regulation of Rag2 transcription was
even greater (6–12-fold) compared to down-regulation
of Rag2 in foetal DN4 wild-type thymocytes (Fig. 3B).
The latter observation suggests that, although pre-TCR
was not necessary for down-regulation of the Rag genes
at the DN4 stage, a strong signal can accelerate down-
regulation of Rag2.
D to J TCRb rearrangement in TCRb–/cd– DN4
thymocytes
To further assess the origin and lineage commitment of
the TCRb–/cd– DN4 cells we analysed the extent of their
DJ TCRb rearrangement. We sorted DN4 TCRb–/cd– and
TCRb/cd+ cells from E16.5 foetal wild-type thymi
(Fig. 3C, D) and performed a PCR-Southern assay to
compare the extend of DJ TCRb rearrangement in the
two cell types, as previously described [17]. We
amplified the TCRb locus from equal amounts of DNA
template from sorted TCRb–/cd– and TCRb/cd+ DN4
cells using Db2- and Jb2.7-specific primers.We observed
similar level of DJ rearrangement in both cell types
(Fig. 3F, G) demonstrating that the TCRb–/cd– DN4 cells
are T lineage committed and suggesting that they
originate from DN2/DN3 cells.
TCRb expression promotes proliferation in foetal
DN4 thymocytes
A gradual decrease in the proportion of icTCRb– DN4
cells during embryogenesis suggests that the foetal DN4
TCRb+ subset expands faster than the DN4 TCRb–
subset. To test whether this is due to increased
proliferation, we sorted E16.5 foetal DN3 and DN4 cells
based on the intracellular expression of b and cd TCR
and analysed proliferation. In a typical experiment,
propidium iodide DNA staining showed that approxi-
mately four-times more TCRb+ DN3 (47.91%) and DN4
(41.06%) cells were in cell cycle than in the TCRb–/cd–
DN3 (10.67%) or DN4 (11.22%) subset (Fig. 4A),
consistent with a pre-TCR induced signal for prolifera-
tion [5, 14, 18–21].
We also tested the possibility that the percentage of
DN4 TCRb–/cd– cells decreased due to active apoptosis
in this subset. We analysed the intracellular expression
of the active form of caspase-3, as it has recently been
shown that pre-TCR up-regulates the anti-apoptotic
gene BCL2A1 that rescues cells from caspase-3-mediated
apoptosis [9]. We were able to detect induction of
apoptosis in control, adult DP cells treated for 2 h with
antiCD3 (Fig. 4B), but the active form of caspase-3 was
virtually absent in both icTCRb–/cd– and icTCRb+ foetal
DN4 thymocytes (Fig. 4C) and among DN3 thymocytes
(data not shown). In contrast in the adult thymus we
were able to detect more apoptotic cells amongst the
icTCRb–/cd– DN4 subset compared to TCRb+ DN4
subset. In a typical experiment 2.91% of icTCRb–/cd–
DN4 cells were caspase-3 positive compared to 0.25% of
the icTCRb+ DN4 cells (Fig. 4C). Our data indicate that
in the foetal thymus, clonotypic TCRb expression
promotes proliferation of DN thymocytes. Lack, how-
ever, of TCRb expression did not immediately induce cell
death in foetal DN4 cells, as evidenced by the absence of
active caspase-3-expressing cells in the DN4 icTCRb–/
cd– population. The increased apoptosis that we
observed in the adult DN4 icTCRb–/cd– population
might be attributed to the accumulation of ageing cells
in this subset.
Abundance of adult TCRb–/cd– DN4 cells after
hydrocortisone treatment
Differentiation of foetal thymocytes occurs in a largely
synchronized wave. In adults, however, thymocyte
production is continuous and the adult thymus has
reached steady state with pre-existing cells at all stages
of development and homeostasis between thymocyte
populations. The difference in the expression of TCRb in
the DN4 subset that we observe between foetal and adult
thymocytes could be due to a foetal restricted capability
of thymocytes to differentiate to the DN4 stage
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Figure 3. Transcription of Rag1 and Rag2 genes
in foetal and adult DN3 and DN4 thymocyte
subsets and TCRb locus rearrangement. (A)
Relative transcription of Rag1 (left graph) and
Rag2 (right graph) in DN3 (full bars) and DN4
(open bars) sorted thymocytes from E15.5,
E16.5 and adult wild-type thymi. DN3 and DN4
cells were sorted to be positive for Thy1.2
expression, negative for CD3, CD4, CD8, CD44
and B220 expression and positive or negative
for CD25 expression, respectively. (B) Tran-
scription of Rag2 in Rag1–/– E16.5 and adult
thymi, cultured for 24 h in the presence or
absence of anti-CD3e antibody is shown for
control (full bars) and treated (open bars)
cultures. (C–G) Db2-Jb2.7 rearrangement of the
TCRb locus in TCRb–/cd– and TCRb/cd+ DN4
wild-type E16.5 foetal thymocytes. TCRb–/cd–
and TCRb/cd+ DN4 foetal thymocytes falling in
the FSC/SSC live gate (C, left) were sorted
negative for CD3/4/8/25/44/B220 and positive
for Thy1.2 (C, middle) and negative or positive
for icTCRb/cd staining, respectively (C, right).
Purity of the sorted populationswas confirmed
by the icTCRb/cd expression profiles shown (D).
Histogram (E) shows the quantification of the
TCRb–/cd– and TCRb/cd+ DN4 thymocyte DNA
preparations as assessed by real time PCR.
Southern hybridisation was performed on PCR
products amplified using specific Db2 and Jb2.7
primers from equal amounts of DNA pre-
parations from each thymocyte subset (F). The
probe used for the southern hybridisation
corresponded to the full-length, germline (GL)
TCRb locus. Quantification of the extent of
Db2-Jb2.7 rearrangement relative to the TCRb–/
cd– thymocytes, calculated for each cell type as
the ratio of the intensity of the band corre-
sponding to the GL sequence divided by the
total intensity of the bands corresponding to
the six rearranged TCRb, is also shown (G).
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independently of normal pre-TCR signalling, either as a
result of differences between foetal and adult hemato-
poietic progenitors [22, 23] or between the foetal and
adult thymic microenvironment [24]. Alternatively, it is
possible that adult TCRb/cd– thymocytes differentiate to
the DN4 stage as efficiently as foetal thymocytes but that
their percentage is very low due to the pre-existing high
number of proliferating TCRb+ DN4 thymocytes that
mask their presence. To distinguish between these two
hypotheses, we synchronized the differentiation of
immature thymocytes by treating adult mice with
hydrocortisone (HC). HC treatment induces apoptosis
of immature DP thymocytes [25] but mature single
positive cells survive treatment and the thymus then
grows exponentially to recover its normal size and
subset distribution a week following the treatment. HC
enabled us to study the differentiation of thymocytes in
the adult thymus in a synchronizedwave and in a rapidly
Figure 4. Proliferation and apoptosis of wild-type foetal thymocytes. (A) DNA content analysis by PI nuclear staining of sorted
CD44–CD3–CD4–CD8–B220–Thy1.2+ TCRb–/cd– CD25+ (DN3, top left histogram) and CD25– (DN4, top right histogram) and TCRb+ DN3
(bottom left histogram) and DN4 (bottom right histogram) cells. Percentages of cells in the S/G2/M phases of the cell cycle are
shown. (B) Intracellular expression of the active form of caspase-3 in DP cells where apoptosis was induced by incubation with
anti-CD3 antibody for 2 h. (C) Intracellular expression of the active form of caspase-3 in foetal and adult DN4 thymocytes.
Histograms on the left show active caspase-3 expression in TCRb–/cd– (top) and TCRb+ (bottom) E16.5 foetal
CD44–CD25–CD3–CD4–CD8–B220– Thy1.2+ (DN4) thymocytes and histograms on the right show active caspase-3 expression in
TCRb–/cd– (top) and TCRb+ adult DN4 populations. Percentages of active caspase-3 positive cells are shown.
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expanding thymus that had not yet reached home-
ostasis. At 3 days after HC treatment, the thymus
contained only 1.27% DP thymocytes (Fig. 5A). Analysis
of intracellular expression of TCRb in DN3 and DN4
cells, identified by the absence of surface expression of
CD3, CD4, CD8, CD44 and B220 markers, the presence
of Thy1.2, and presence or absence, respectively, of
CD25 (Fig. 5B) showed that the percentage of cells
expressing TCRbwas equivalent between DN3 (11.59%)
and DN4 (10.13%) populations (Fig. 5C, top panel). At
4 days after HC treatment, the percentage of icTCRb+
cells in the DN4 population significantly increased to
48.49% compared to 13.32% of DN3 cells (Fig. 5C,
middle panel). At 7 days after treatment, the percentage
of TCRb+ DN4 cells had reverted back to the percentage
observed in non-treated wild-type adult mice with
typically 15.37% of DN3 and 90.02% of DN4 cells
staining positive for icTCRb+ (Fig. 5C, lower panel), and
90.36% of thymocytes were CD4+CD8+DP, indicating
that the thymus had fully recovered (data not shown).
Although the absolute number of DN3, DN4 TCRb–/cd–
and DN4 TCRb+ cells increased overtime, there was
preferential expansion of the DN3 and TCRb+ DN4
populations (Fig. 5D).
To assess cell cycle status in the DN4 population, we
compared cyclin B1 expression in the TCRb–/cd– and
TCRb+ DN4 thymocytes at 3 and 4 days after HC
treatment (Fig. 6A). Approximately four times more
cells in the TCRb+ DN4 compartment showed high
intensity cyclin B1 staining (Fig. 6A), indicative of cells
in the S/G2/M stages of the cell cycle, than in the
TCRb–/cd– DN4 population, indicating that TCRb
expression (and hence pre-TCR signalling) induces
expansion.
We also analysed apoptosis of the DN4 thymocytes 4,
6 and 7 days after HC treatment by caspase-3 staining.
Apoptosis was virtually undetectable 4 days after
treatment in both TCRb–/cd– (0.16%) and TCRb+
(0.06%) DN4 cells (Fig. 6B, left). In contrast, at 6 days
after treatment, the percentage of apoptotic cells was
significantly higher in TCRb–/cd– DN4 cells (2.39%)
than in TCRb+ DN4 cells (0.35%, Fig. 6B, middle) and
had further increased 7 days after treatment to 4%,
whereas no increase in apoptosis was observed in the
TCRb+ DN4 subset (0.26%, Fig. 6B, right).
In summary, in the synchronised and rapidly
expanding HC-treated adult thymus, we were able to
detect a large percentage of TCRb–/cd– adult DN4
thymocytes, similar to that observed in the foetal
thymus. Thus, the rarity of TCRb–/cd– DN4 cells in
the normal adult thymus cannot be attributed to an
intrinsic inability of either adult lymphoid or stromal
compartments to support pre-TCR independent differ-
entiation to DN4. Our experiments suggest that the
decrease in the ratio of TCRb–/cd–:TCRb+ DN4 cells
after treatment is due to pre-TCR induced expansion of
the TCRb+ subset rather than apoptosis of the TCRb–/
cd– DN4 population. The detection of significantly more
apoptotic cells in the TCRb–/cd– DN4 subset in non-
treated adults and 7 days after HC treatment seems to
reflect ageing cells accumulating in this subset rather
than immediate induction of apoptosis due to lack of
pre-TCR signalling.
Reduced proliferation, increased apoptosis in
foetal Rag1–/– DN4 versus DN3
To account for the virtual absence of DN4 cells in Rag1–/–
adult thymus compared to the readily detectable
population in the Rag1–/– foetal thymus, we analysed
proliferation and apoptosis of Rag1–/– DN3 and DN4
cells during embryonic development and in the adult
Rag1–/– thymus. On all embryonic days tested the
percentage of DN4 cells that were in cell cycle, as
assessed by the intensity of cyclin B1 staining, was lower
than the corresponding percentage of DN3 cells, and the
percentage of cycling cells decreased over time in both
DN3 and DN4 subsets (Fig. 7A). Interestingly, the ratio
of cycling cells in the DN3 relative to the DN4 population
increased sixfold between foetal and adult thymus,
accounting for the decline in the DN4 population
(Fig. 7B).
Staining for the active form of caspase-3 revealed
that, contrary to the data obtained from the wild-type
foetal thymus, apoptotic cells were present in Rag1–/–
foetal DN3 and DN4 subsets and their percentage was
higher in the DN4 subset (Fig. 7C, D). In a typical
experiment the percentage of apoptotic cells in the DN3
subset varied from 0.31% and 0.63% for E15.5–17.5 and
from 0.89% to 1.58% in the DN4 subset (Fig. 7C). In the
adult Rag1–/– thymus, we were only able to detect a very
small percentage of active caspase-3-positive cells in
both the DN3 (0.02%) and the DN4 (0.14%) subsets
(Fig. 7C) and there was no significant difference in the
percentage of apoptotic cells between the two subsets
(Fig. 7D). The observed increase in apoptosis in the
foetal DN4 subset relative to the DN3 subset during
ontogeny provides an additional explanation for the
decline of the DN4 population.
Discussion
Here we showed that in the foetal thymus down-
regulation of CD25 cell surface expression and differ-
entiation to the DN4 stage can occur independently of
TCRb expression and hence pre-TCR signalling. Rare
TCRb–/cd– DN4 cells in adult mice have been previously
reported [7, 15], but we showed that in contrast to the
adult thymus, most DN4 thymocytes in the E15.5 foetal
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Figure 5. Expression of TCRb in thymo-
cytes that differentiated following
hydrocortisone treatment. (A) CD4 and
CD8 expression profiles of HC-treated
thymus 3 days after treatment.
(B) Identification of DN3 and DN4 sub-
sets. Cells were selected to be negative
for CD3, CD4, CD8, CD44 and B220 and
positive for Thy1.2 expression (left). DN3
cells were selected positive for CD25
expression and DN4 cells negative for
CD25 expression (right). Representative
dot plots are shown for thymocytes
prepared 3 days after HC treatment.
(C) Intracellular expression of TCRb in
DN3 (lighter shaded histograms) and
DN4 (darker shaded histograms) popu-
lations 3, 4 and 7 days after HC treat-
ment. Percentages of icTCRb+ cells are
shown. (D) Graph representing the
kinetics of DN3, DN4 TCRb–/cd– and DN4
TCRb+ cell numbers in the HC-treated
mice. Open bars represent the absolute
number of DN3 thymocytes, light shaded
bars of DN4 TCRb–/cd– thymocytes and
darker bars of DN4TCRb+ thymocytes 3, 4
and 7 days after HC treatment.
Mean thymocyte numbers were at
day 3 (0.43  0.06)  107,
day 4 (0.78  0.14)  107
and day 7 (6.92  1.65)  107.
Mean DN4 TCRb–/cd– thymocyte
numbers were
at day 3 (0.23  0.06)  105,
at day 4 (0.43  0.15)  105
and at day 7 (2.15  0.52)  105.
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thymus were icTCRb–/cd–. These TCRb–/cd–
CD25–CD44– thymocytes were T lineage, based on
expression of Thy1 and icCD3, and TCRb DJ rearrange-
ment. Likewise, we found a normal percentage of DN4
cells in the early Rag1–/– foetal thymus, despite their
inherent inability for TCRb/cd rearrangement and
expression.
Most DN4 cells that emerged after HC treatment of
adult mice were also icTCRb–/cd–. The abundance of
TCRb–/cd– DN4 cells in the HC-treated adult thymus
demonstrated that their production was not foetal-
restricted and that both adult lymphoid and stromal
elements are capable of supporting differentiation to
DN4 in the absence of TCRb/cd expression. This
similarity with the foetal thymus could reflect the
synchronicity of the transition in both cases (enabling
the identification of normally undetectable TCRb–/cd–
that would physiologically make the transition from
DN3 to DN4 in the adult thymus). Alternatively, the
production of TCRb–/cd– DN4 cells in the adult HC-
treated thymus could be a direct consequence of the
treatment, as regeneration and rapid growth are
induced. During embryogenesis, the foetal thymus also
expands exponentially. It therefore remains to be
determined to what extent pre-TCR independent
mechanisms of differentiation from DN3 to DN4 occur
in the adult thymus under physiological conditions, but
clearly TCRb/cd expression independent differentiation
from DN3 to DN4 is important in the foetal thymus. It
likewise remains to be determined if low-level signalling
through other components of the pre-TCR complex in
the absence of TCRb expression, such as CD3 polypep-
tides, would be sufficient to drive down-regulation of
CD25.
The fact that DN4 thymocytes are found in the foetal
Rag1–/– thymus is important for the interpretation of the
phenotype of other genetically altered mice that have
arrested thymocyte development. For example, parti-
cularly in the foetus, the appearance of DN4 cells may
have lead to the assumption that a mutation affected
processes following pre-TCR signalling when in fact this
might not necessarily be the case.
There are several studies indicating that pre-TCR
signalling and b-selection induce proliferation [5, 14,
Figure 6. Proliferation and apoptosis in DN4 population after HC treatment. (A) The left panel is the percentages of icTCRb–/cd– and
icTCRb+ DN4 cells positive for high level of intracellular expression of cyclin B1, indicative of cells at the S/G2/M cell cycle stages.
Bars represent the mean of five mice analysed 3 days (open bars) and 4 days (black bars) after HC treatment. The right panel is
representative histogram overlay of intracellular cyclin B1 staining of icTCRb–/cd– (full histogram) and icTCRb+ (empty histogram)
DN4 cells 4 days after HC treatment. (B) Intracellular expression of the active form of caspase-3 in DN4 thymocytes after HC
treatment. Histograms show caspase-3 expression in TCRb–/cd– (shaded histograms) and TCRb+ (open histograms) DN4
thymocytes after 4 days (left), 6 days (middle) and 7 days (right). Percentages of active caspase-3-positive cells are shown.
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18–21]. We also demonstrated directly, both by PI and
anti-cyclin B1 staining that four times more TCRb+ cells
were dividing in both the foetal and HC-treated adult
thymus, compared to the TCRb–/cd– DN4 population.
We found more proliferating cells in both foetal TCRb+
and TCRb–/cd– DN4 cells than in their adult counter-
parts, consistent with the exponential increase in
thymocyte number during embryogenesis. In addition,
it is worth noting that we detected some cell division in
all thymocyte populations examined, including the
TCRb–/cd– DN4 population, suggesting the existence
of pre-TCR independent mechanisms of proliferation, as
previously reported [7, 26].
It has been shown that the pre-TCR can promote cell
survival by induction of anti-apoptotic agents [9] and
that cell death is increase in the adult TCRb– DN4
population relative to the adult TCRb+ DN4 [7]. The
experiments of Falk and others [7] correlated cell
Figure 7. Proliferation and apoptosis of Rag1–/– foetal and adult DN thymocytes. (A) Percentages of DN3 (open bars) and DN4
(shaded bars) Rag1–/– cells positive for high expression of cyclin B1 in thymi at E14.5, E15.5, E16.5 and, E17.5 and adult thymus. Bars
represent data from at least three animals and error bars are shown. (B) Ratio of proliferation of DN3 relative to DN4 cells as in (A).
(C) Intracellular expression of the active form of caspase-3 in DN3 (open histograms) and DN4 (shaded histograms) subsets of
Rag1–/– E15.5, E16.5, E17.5 and adult thymocytes. Percentages of caspase-3-positive cells are shown. (D) Mean percentages of active
caspase-3-positive DN3 (open bars) and DN4 (shaded bars) E15.5, E16.5, E17.5 and adult thymocytes. Bars represent data from at
least three animals and error bars are shown.
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surface CD69 expression with absence of icTCRb/cd in
the DN4 population, and then demonstrated relatively
more apoptosis in the CD69+ DN4 population than in
the CD69– DN4 cells. Consistent with this study, our
analysis confirms directly an increase in apoptosis of
TCRb–/cd– DN4 cells relative to TCRb+ DN4 cells in the
adult thymus (Fig. 4C). Our experiments suggest,
however, that absence of the pre-TCR complex does
not immediately induce apoptosis as we did not observe
apoptosis amongst the foetal or recently differentiated
adult DN4 cells either by caspase-3 or annexin-V staining
(Fig. 4 and 6, and data not shown), regardless of the
presence or absence of TCRb/cd. The increase in
apoptosis in the TCRb–/cd– DN4 population on succes-
sive days after HC treatment is consistent with
accumulation of ageing cells and absence of pre-TCR
induced pro-survival signals that are up-regulated in the
TCRb+ DN4 population [9]. The proportion but not the
number of icTCRb–/cd–DN4 cells greatly decreased over
time, and was very low in the fully developed adult
thymus. Taken together our experiments indicate that
the age-dependent decline in the proportion of TCRb–
DN4 cells is due to pre-TCR induced proliferation of the
TCRb+ DN4 subset, rather than immediate induction of
apoptosis in cells that fail to pass the b-selection check-
point at the DN3 stage.
The fate of the TCRb–/cd– DN4 cells is unclear. In the
foetal and HC-treated adult thymus, there was no
enrichment for TCRb+ cells in the DN4 subset compared
to the DN3 population. It is possible that some wild-type
TCRb–/cd– DN4 cells eventually rearrange and express
TCRb or TCRcd and continue their maturation, but the
foetal Rag1–/– DN4 thymocytes clearly cannot progress
beyond the DN4 stage as neither DP nor SP cells are
observed in either the foetal or adult Rag1–/– thymi. We
showed that the foetal Rag1–/– DN4 population is
disadvantaged compared to the DN3 population due to
both reduced proliferation and increased apoptosis,
explaining the virtual absence of DN4 cells in the adult
thymus. In addition, the presence of apoptotic Rag1–/–
DN3 and DN4 cells, not detectable in the equivalent
wild-type populations and the reduced proliferation in
the Rag1–/– foetal compared to wild-type thymocyte
populations seem to reflect differences in the thymic
microenvironment of Rag1–/– and wild-type thymus.
This is consistent with a previous report showing that the
reduced proliferation of adult Rag2–/– compared towild-
type thymocytes was at least partly due to differences in
the thymus environment rather than the absence of cell
autonomous, pre-TCR related proliferation signals in the
Rag2–/– thymocytes [26].
In conclusion, we have shown that in the foetal
thymus the transition from the DN3 to the DN4 stage is
frequently independent of pre-TCR signalling. Our data
also suggest that pre-TCR signalling induces prolifera-
tion and that lack of it does not immediately induce
apoptosis.
Materials and methods
Mice
Wild-typemice were C57BL/6, purchased from B& K Universal
Ltd (UK) and Rag1–/– [10] mice were purchased from Jackson
Laboratories, USA. All mice were bred and maintained at the
Central Biomedical Services unit at Imperial College London
according to UK Home Office regulations.
Timed mates were performed by mating a male with two
females overnight and monitoring the females for plugs. The
day the plug was found was counted as E0.5.
Flow cytometry and antibodies
Thymocyte suspensions were prepared by crushing thymi
between two pieces of ground glass. Cells were stained using
combinations of directly conjugated antibodies obtained from
BD Pharmingen: anti-CD44FITC, anti-CD44PE,
anti-CD44Cychrome, anti-CD25 PE, anti-CD25 FITC, anti-CD4FITC,
anti-CD4PE, anti-CD4Cychrome, anti-CD8 a FITC, anti-CD8 a PE,
anti-CD8a Cychrome, anti-CD3 Cychrome, anti-CD45.2FITC, anti-
Thy1.2FITC, anti-HSAPE, anti-NK1.1FITC, anti-B220Cychrome,
anti-TCRbPE, and anti-TCRcdPE.
Cell suspensions were stained with the antibodies for
30 min on ice in 50 ll Dulbecco's modified medium (Life
Technologies), supplemented with 5% FCS and 0.01% sodium
azide. Cells were washed in this medium between incubations
and prior to analysis on the FACScan (Becton Dickinson).
Events were collected in list mode using CellQuest software
and data analysed using CellQuest Pro software. Live cells were
gated according to their FSC and SSC profiles. Data are
representative of at least three experiments.
Intracellular staining for TCRb, TCRc/d, CD3, cyclin B1 and
caspase-3 was performed on cells stained for surface markers
as above following fixation and permeabilisation with the
Cytofix/CytopermTM solutions (BD biosciences) according to
the manufacturer's instructions.
PI (Sigma) staining was carried out on sorted thymocytes
treated with 100 lg/mL RNase (Sigma) and permeabilised in
0.1% Triton X-100, as described previously [27]. Cell cycle
analysis was carried out using a doublet-discrimination
module on the FACScan.
C57BL/6J E15.5 and E16.5 foetal and adult thymocytes
were sorted on a Modular Flow Cytometer (MoFlo, Cytoma-
tion, Inc., Fort Collins, CO) at the Cancer Research UK FACS
laboratory. For purification of DN3 and DN4 populations for
the real time RT-PCR analysis of Rag1 and Rag2 transcription,
cells falling within the FSC/SSC live gate,>98% of which were
CD45.2+, were sorted using antibodies directed against
CD25FITC, CD3/CD4/CD8PE and CD44Cychrome. TCRb–/cd–
and TCRb+ DN4 thymocytes were isolated as described in
Fig. 3C, D, falling within the FSC/SSC live gate and staining
negative for CD3/CD4/CD8/CD25/CD44/B220 and positive
for Thy1.2 and negative or positive for icTCRb/cd or icTCRb
antibody staining, respectively.
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Foetal and adult thymus organ cultures
Foetal and adult thymi were cultured on 8-lm pore size
Millipore filters (Millipore) in AIM-V serum free medium (Life
Technologies) at 37C and 5% CO2 with 1 lg/mL azide-free
anti-CD3 (BD Pharmingen) as previously described [17].
Real-time RT-PCR analysis
RNA was extracted from the sorted thymocytes with the
Absolutely RNA miniprep kit (Stratagene) and cDNA was
synthesized with Superscript III (Invitrogen, Carlsbad, CA).
The cDNA samples were analysed in triplicate by real-time PCR
on an iCycler (Bio-Rad Laboratories) using the iQTMSYBRJ
Green Supermix (Bio-Rad) according to the manufacturer's
instructions and as previously described [17]. At least one
primer for each amplification pair was designed to span exon-
exon boundaries to avoid amplification of genomic DNA. For
the amplification of Rag1 transcripts, we used primers Rag1
exon 2 CCTTTGAGGTTTCTCTAAC and Rag1 exon 2–3
TCCTGCTACTAAAATCTCC, and for the amplification of
Rag2 transcripts we used Rag2 forward CTGGCTTG-
GCCGAAAGG and Rag2 reverse CTGCTTGTGGATGTGAAA-
TACTCT.
Quantification of TCRb locus rearrangements
TCRb–/cd– and TCRb/cd+ DN4 thymocytes were sorted from
E16.5 foetal thymi as described above, DNA was extracted
using the DNeasy tissue kit (Qiagen) and D to J PCR-Southern
hybridisation assay was carried out as previously described
[17]. In brief, 24 cycles of PCR amplification for the D to J
TCRb rearrangements were performed using the following
primers: Db2 (50) GTAGGCACCTGTGGGGAAGAAACT and
Jb2.7 (30) TGAGAGCTGTCTCCTACTATCGATT, and the am-
plified products were quantified by Southern blotting using a
TCRb probe amplified from germline (unrearranged) TCRb
locus with Db2 and Jb2.7 primers, corresponding to the
genomic region between the TCRDb2 and TCRJb2.7 as
previously described [17].
The genomic DNA concentration of the templates for the D
to J PCR-Southern assay were quantified by real time PCR on
an iCycler using primers specific for a single copy genomic
locus 50G2FAGAACCTGAAGACACACCTGCG and 30G2R
GAGGCATTGGAGAAGGCTTTG.
HC treatment
For the deletion of immature thymocytes and synchronization
of thymocyte development in adult thymus, 4–8-week-old
C57BL/6 mice were injected intraperitoneally with 0.4 mg/g
HC sodium phosphate (Sigma), diluted in sterile PBS [25].
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